As of 12:31 PM on the 13th, Celltrion is trading at 386,000 KRW, up 0.52% from the previous day. This marks a 15.74% increase compared to December 28. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

Today, foreigners have net sold 52,194 shares of Celltrion, and institutions have net sold 1,000 shares, according to provisional data. Over the past five days, individual investors have net bought 782,096 shares, while foreigners and institutions have net sold 387,620 shares and 409,617 shares, respectively.


On January 11, Celltrion was a market topic with the news of the start of domestic clinical trials for 'CT-P43,' leading to a strong performance.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing